OQROGet OQRO Pro
Insider trade

Cardiff Oncology (CRDF)Director bought ~$910K

Gary W Pace, Director at Cardiff Oncology, bought ~$910K of Cardiff Oncology shares.

~$910K
Approx. value · 350K sh @ $2.60
1.05M
Holds after · shares reported
Traded
Dec 11, 2024
Filed
Dec 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024 · this disclosureInsiderDirector purchased ~$910K of CRDF shares in the open market

What came next

  1. Dec 11, 2024InsiderDirector purchased ~$30K of CRDF shares in the open market
  2. Dec 12, 2024InsiderDirector purchased ~$34K of CRDF shares in the open market
  3. Dec 16, 2024InsiderCFO purchased ~$9.8K of CRDF shares in the open market
  4. Dec 17, 2024InsiderCFO purchased ~$15K of CRDF shares in the open market
  5. Dec 18, 2024InsiderCFO purchased ~$12K of CRDF shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cardiff Oncology

For Cardiff Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRDF page.

Other recent filings by Gary W Pace, Director

The full history of Gary W Pace, Director is on the profile page.

How this filing works

Other disclosures at Cardiff Oncology

Everything OQRO holds on this company is on its CRDF page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data